Perth, June 23, 2015 - (ABN Newswire) - PhytoTech Medical Limited (ASX:PYL) today advises that the newly designed corporate website is now live and available at http://www.phytotechmed.com.
The Medical Cannabis industry is relatively new in Australia and as the first medical cannabis company to list on the ASX, PhytoTech intends to use its website to provide the investment community with the knowledge to understand its business and the industry better.
The Company encourages shareholders to visit the website to access up-to-date industry news and details on the Company's activities and its products in the development pipeline.
About: PhytoTech Medical Limited
PhytoTech Medical (ASX:PYL) is a medical cannabis company, which aims to commercialize Medical Grade Cannabis (MGC) and high potential cannabis based therapeutics products to the rapidly growing international market with regulated medical cannabis legislation. With research facilities located in Israel, a global leader in medical cannabis research, the Company is strategically positioned to become a key player in the global MGC market.
The Company is focused on the research, development and commercialization of products for administering MGC, and on new treatments utilizing MGC therapeutic components for various medical conditions. In addition, the Company aims to grow proprietary strains of MGC in California, Uruguay and other jurisdictions.
Help employers find you! Check out all the jobs and post your resume.
The Medical Cannabis industry is relatively new in Australia and as the first medical cannabis company to list on the ASX, PhytoTech intends to use its website to provide the investment community with the knowledge to understand its business and the industry better.
The Company encourages shareholders to visit the website to access up-to-date industry news and details on the Company's activities and its products in the development pipeline.
About: PhytoTech Medical Limited
PhytoTech Medical (ASX:PYL) is a medical cannabis company, which aims to commercialize Medical Grade Cannabis (MGC) and high potential cannabis based therapeutics products to the rapidly growing international market with regulated medical cannabis legislation. With research facilities located in Israel, a global leader in medical cannabis research, the Company is strategically positioned to become a key player in the global MGC market.
The Company is focused on the research, development and commercialization of products for administering MGC, and on new treatments utilizing MGC therapeutic components for various medical conditions. In addition, the Company aims to grow proprietary strains of MGC in California, Uruguay and other jurisdictions.
Help employers find you! Check out all the jobs and post your resume.
